M. Bischoff

713 total citations
20 papers, 499 citations indexed

About

M. Bischoff is a scholar working on Hematology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Bischoff has authored 20 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 6 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Bischoff's work include Hematopoietic Stem Cell Transplantation (10 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Nausea and vomiting management (2 papers). M. Bischoff is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Nausea and vomiting management (2 papers). M. Bischoff collaborates with scholars based in Germany, Austria and Switzerland. M. Bischoff's co-authors include D Kirsten, S Günzelmann, A. A. Fauser, Nadežda Basara, Eric J. Romer, AA Fauser, N Basara, Michael Kiehl, IW Blau and M. Tryba and has published in prestigious journals such as Clinical Infectious Diseases, Supportive Care in Cancer and Bone Marrow Transplantation.

In The Last Decade

M. Bischoff

20 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Bischoff Germany 12 244 97 92 86 84 20 499
Rozita Hoseini Iran 12 15 0.1× 58 0.6× 14 0.2× 43 0.5× 53 0.6× 56 388
Shashi Nagaraj United States 11 23 0.1× 137 1.4× 6 0.1× 25 0.3× 36 0.4× 23 530
Joel C. Reynolds United States 10 13 0.1× 72 0.7× 11 0.1× 120 1.4× 131 1.6× 13 438
S B Leapman United States 8 40 0.2× 95 1.0× 4 0.0× 18 0.2× 35 0.4× 17 323
U. Nowak-Göttl Germany 10 319 1.3× 59 0.6× 9 0.1× 11 0.1× 16 0.2× 20 432
O. Saarinen Finland 11 22 0.1× 167 1.7× 6 0.1× 11 0.1× 36 0.4× 26 351
Ali Ataya United States 11 23 0.1× 185 1.9× 18 0.2× 28 0.3× 5 0.1× 90 418
Cristina Arnal Spain 12 204 0.8× 71 0.7× 22 0.2× 66 0.8× 19 529
Sameep Sehgal United States 11 10 0.0× 182 1.9× 19 0.2× 29 0.3× 17 0.2× 27 339
Ilkka Mattila Finland 15 12 0.0× 257 2.6× 9 0.1× 59 0.7× 26 0.3× 56 656

Countries citing papers authored by M. Bischoff

Since Specialization
Citations

This map shows the geographic impact of M. Bischoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Bischoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Bischoff more than expected).

Fields of papers citing papers by M. Bischoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Bischoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Bischoff. The network helps show where M. Bischoff may publish in the future.

Co-authorship network of co-authors of M. Bischoff

This figure shows the co-authorship network connecting the top 25 collaborators of M. Bischoff. A scholar is included among the top collaborators of M. Bischoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Bischoff. M. Bischoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wolf, Robert Christian, Barbara Käsmann‐Kellner, M. Bischoff, et al.. (2016). PONV nach Strabismus-OP. Der Anaesthesist. 65(7). 507–513. 6 indexed citations
2.
Bein, Thomas, M. Bischoff, Dietrich Henzler, et al.. (2015). Kurzversion S2e-Leitlinie – „Lagerungstherapie und Frühmobilisation zur Prophylaxe oder Therapie von pulmonalen Funktionsstörungen“. Der Anaesthesist. 64(8). 596–611. 21 indexed citations
3.
Bein, Thilo, M. Bischoff, Dietrich Henzler, et al.. (2015). S2e guideline: positioning and early mobilisation in prophylaxis or therapy of pulmonary disorders. Der Anaesthesist. 64(S1). 1–26. 93 indexed citations
4.
Böckler, Dittmar, A. Peters, Steffi Pfeiffer, et al.. (2014). Nellix® Endovascular Aneurysm Sealing (EVAS) – eine neue Technologie zur endovaskulären Ausschaltung infrarenaler Aortenaneurysmen. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 139(5). 562–568. 7 indexed citations
5.
Muehling, Bernd M., et al.. (2010). A New Treatment Concept for Bronchial Stump Insufficiency. The Thoracic and Cardiovascular Surgeon. 58(3). 169–174. 2 indexed citations
6.
Bischoff, M., et al.. (2004). Reperfusion, Infektbekämpfung und Defektdeckung - Aktueller Stand der Wundbehandlung - ein Überblick. Der Klinikarzt. 33(08/09). 239–245. 1 indexed citations
7.
Kiehl, M. G., et al.. (2001). A prospective randomized trial comparing the efficacy and safety of piperacillin/tazobactam versus piperacillin/tazobactam plus netilmicin in the treatment of febrile neutropenia in allogeneic stem cell recipients. 41. 267. 2 indexed citations
8.
Blau, IW, N Basara, Giuseppe Lentini, et al.. (2001). Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study. Bone Marrow Transplantation. 27(1). 27–33. 18 indexed citations
9.
Basara, Nadežda, M. G. Kiehl, Eric J. Romer, et al.. (2001). Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience. Transplantation Proceedings. 33(3). 2121–2123. 38 indexed citations
10.
Basara, Nadežda, Michael Kiehl, M. Bischoff, et al.. (2001). Toxoplasmosis, a Severe Complication in Allogeneic Hematopoietic Stem Cell Transplantation: Successful Treatment Strategies during a 5-Year Single-Center Experience. Clinical Infectious Diseases. 32(1). e1–e8. 49 indexed citations
11.
Blau, IW, N Basara, M. Bischoff, et al.. (2000). Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant. Bone Marrow Transplantation. 25(1). 41–45. 33 indexed citations
12.
Basara, N, et al.. (2000). Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA‐mismatched bone marrow transplant patients. Clinical Transplantation. 14(2). 121–126. 37 indexed citations
13.
Basara, Nadežda, IW Blau, M. Bischoff, et al.. (2000). Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study. Bone Marrow Transplantation. 25(4). 371–376. 16 indexed citations
14.
Blau, IW, N Basara, Annerose Serr, et al.. (1999). A second unrelated bone marrow transplant: successful quantitative monitoring of mixed chimerism using a highly discriminative PCR-STR system. Clinical & Laboratory Haematology. 21(2). 133–138. 10 indexed citations
15.
Basara, Nadežda, Igor‐Wolfgang Blau, Michael Kiehl, et al.. (1998). Chronic Eosinophilic Leukemia: Successful Treatment with an Unrelated Bone Marrow Transplantation. Leukemia & lymphoma. 32(1-2). 189–193. 21 indexed citations
16.
Basara, N, M. Bischoff, IW Blau, et al.. (1998). A second unrelated bone marrow transplant with an unrelated donor marrow: treatment of a patient with relapsed leukemia. Bone Marrow Transplantation. 21(3). 291–293. 13 indexed citations
17.
Basara, Nadežda, Eric J. Romer, M. Bischoff, et al.. (1998). Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients. Bone Marrow Transplantation. 22(1). 61–65. 81 indexed citations
18.
19.
Basara, Nadežda, Michael Kiehl, Eric J. Romer, et al.. (1998). Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient. Transplantation Proceedings. 30(8). 4087–4089. 30 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rozita Hoseini Breakdown of academic impact, for papers by Shashi Nagaraj Breakdown of academic impact, for papers by Joel C. Reynolds Breakdown of academic impact, for papers by S B Leapman Breakdown of academic impact, for papers by U. Nowak-Göttl Breakdown of academic impact, for papers by O. Saarinen Breakdown of academic impact, for papers by Ali Ataya Breakdown of academic impact, for papers by Cristina Arnal Breakdown of academic impact, for papers by Sameep Sehgal Breakdown of academic impact, for papers by Ilkka Mattila
Rankless by CCL
2026